Official Full Name |
Recombinant Murine Thymus and Activation Regulated Chemokine/CCL17 (rMuTARC/CCL17) |
Squence |
 |
Amino Acid Sequence |
ARATNVGREC CLDYFKGAIP IRKLVSWYKT SVECSRDAIV FLTVQGKLIC ADPKDKHVKK AIRLVKNPRP |
Synonyms |
|
Accession Number |
|
GeneID |
|
Summary |
|
Source |
|
Molecular Weight |
|
Biological Activity |
Fully biologically active when compared to standard. The biologically active determined by a chemotaxis bioassay using human T-lymphocytes is in a concentration range of 1.0-10 ng/ml. |
Appearance |
Sterile Filtered White lyophilized (freeze-dried) powder. |
Formulation |
Lyophilized from a 0.2 um filtered concentrated solution in PBS, pH 7.4. |
Endotoxin |
Less than 1 EU/ug of rMuTARC/CCL17 as determined by LAL method. |
Reconstitution |
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/ml. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions. |
Stability and Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.- 12 months from date of receipt, -20 to -70 °C as supplied.- 1 month, 2 to 8 °C under sterile conditions after reconstitution.- 3 months, -20 to -70 °C under sterile conditions after reconstitution. |
References |
1. Loftus BJ, Kim UJ, Sneddon VP, et al. 1999. Genomics, 60: 295-308.2. Imai T, Baba M, Nishimura M, et al. 1997. J Biol Chem, 272: 15036-42.3. Imai T, Yoshida T, Baba M, et al. 1996. J Biol Chem, 271: 21514-21.4. Jakubzick C, Wen H, Matsukawa A, et al. 2004. Am J Pathol, 165: 1211-21.5. Shimada Y, Takehara K, Sato S. 2004. J Dermatol Sci, 34: 201-8.6. Sumiyoshi K, Nakao A, Setoguchi Y, et al. 2003. J Dermatol Sci, 31: 53-8. |
SDS-PAGE |
 |
Safety Data Sheet (SDS) Download |
Click to download |
Technical Data Sheet (TDS) Download |
Click to download |